Feb 9, 2026Gene Therapy for Aging: Telomerase Activation, AAV Delivery, Current Trials, and RisksGene therapy to extend healthspan is moving from animal studies to human trials. Telomerase activation via AAV delivery extended lifespan in mice. Human applications are in early development. The risks — including oncogenic potential — are significant and must be understood clearly.